Fig. 3
From: Biologic predictors of clinical improvement in rituximab-treated refractory myositis
Changes in muscle VAS at 16 weeks by conjuction of serum IFN chemokine scores and autoAb groups. a Changes in Muscle VAS at 16 weeks with serum IFNCK score. b Changes in Muscle VAS at 16 weeks with TH1 score. c Changes in Muscle VAS at 16 weeks with TH17 scores
